Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,308Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10ABBVIE

02 12HARROW EYE

03 5SUN PHARM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 8648048

Drug Substance Claim :

Drug Product Claim :

Application Number : 50790

Patent Use Code : U-1483

Delist Requested : Y

Patent Use Description : INCREASE TEAR PRODUCTI...

Patent Expiration Date : 2024-08-27

Abbvie Company Banner

02

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 8633162

Drug Substance Claim :

Drug Product Claim :

Application Number : 50790

Patent Use Code : U-1479

Delist Requested : Y

Patent Use Description : INCREASE TEAR PRODUCTI...

Patent Expiration Date : 2024-08-27

Abbvie Company Banner

03

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 9248191

Drug Substance Claim :

Drug Product Claim :

Application Number : 50790

Patent Use Code : U-1479

Delist Requested : Y

Patent Use Description : INCREASE TEAR PRODUCTI...

Patent Expiration Date : 2024-08-27

Abbvie Company Banner

04

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 8629111

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2024-08-27

Abbvie Company Banner

05

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 8685930

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2024-08-27

Abbvie Company Banner

06

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 8292129

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-02-25

Abbvie Company Banner

07

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 9676525

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-07

Abbvie Company Banner

08

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 9669974

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-05-11

Abbvie Company Banner

09

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 8561859

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-16

Abbvie Company Banner

10

arrow
2024 ACI Convention
Not Confirmed

CYCLOSPORINE

US Patent Number : 8642556

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50790

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2024-08-27

Abbvie Company Banner